Pivotal Bioventure Partners Fund I, L.p. - Net Worth and Insider Trading
Pivotal Bioventure Partners Fund I, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Pivotal Bioventure Partners Fund I, L.p. owns 3 companies in total, including Inozyme Pharma Inc (INZY) , Akouos Inc (AKUS) , and Entasis Therapeutics Holdings Inc (ETTX) .
Insider Ownership Summary of Pivotal Bioventure Partners Fund I, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| INZY | Inozyme Pharma Inc | 2023-08-01 | director |
| AKUS | Akouos Inc | 2020-06-25 | 10 percent owner |
| ETTX | Entasis Therapeutics Holdings Inc | 2018-09-25 | 10 percent owner |
Pivotal Bioventure Partners Fund I, L.p. Trading Performance
Pivotal Bioventure Partners Fund I, L.p. Ownership Network
Ownership Network List of Pivotal Bioventure Partners Fund I, L.p.
Ownership Network Relation of Pivotal Bioventure Partners Fund I, L.p.
Pivotal Bioventure Partners Fund I, L.p. Owned Company Details
What does Inozyme Pharma Inc do?
Who are the key executives at Inozyme Pharma Inc?
Pivotal Bioventure Partners Fund I, L.p. is the director of Inozyme Pharma Inc. Other key executives at Inozyme Pharma Inc include director & 10 percent owner Robert Lorne Hopfner , COO Matthew Winton , and See Remarks Henric Bjorn Bjarke .
Inozyme Pharma Inc (INZY) Insider Trades Summary
Over the past 18 months, Pivotal Bioventure Partners Fund I, L.p. made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 1,281,265 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .
In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 2,114,598 shares were bought by its insiders, resulting in a net purchase of 2,107,075 shares.
Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.
Inozyme Pharma Inc Insider Transactions
Pivotal Bioventure Partners Fund I, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Pivotal Bioventure Partners Fund I, L.p.. You might contact Pivotal Bioventure Partners Fund I, L.p. via mailing address: 501 Second Street, Suite 200, San Francisco Ca 94107.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
